How big is the China Self-Monitoring Blood Glucose Devices Market?

The China Self-Monitoring Blood Glucose Devices Market size is expected to reach USD 1.30 billion in 2024 and grow at a CAGR of 6.20% to reach USD 1.60 billion by 2029. Read More

What is the current China Self-Monitoring Blood Glucose Devices Market size?

In 2024, the China Self-Monitoring Blood Glucose Devices Market size is expected to reach USD 1.30 billion. Read More

Who are the key players in China Self-Monitoring Blood Glucose Devices Market?

Roche Diabetes Care, Abbott Diabetes Care, LifeScan, Arkray and Sinocare are the major companies operating in the China Self-Monitoring Blood Glucose Devices Market. Read More

What years does this China Self-Monitoring Blood Glucose Devices Market cover, and what was the market size in 2023?

In 2023, the China Self-Monitoring Blood Glucose Devices Market size was estimated at USD 1.22 billion. The report covers the China Self-Monitoring Blood Glucose Devices Market historical market size for years: 2018, 2019, 2020, 2021, 2022 and 2023. The report also forecasts the China Self-Monitoring Blood Glucose Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

China Self-Monitoring Blood Glucose Devices Companies

This report lists the top China Self-Monitoring Blood Glucose Devices companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the China Self-Monitoring Blood Glucose Devices industry.